Twitter summary: AACE/ACE publish position statement on obesity w/ 4 step plan: screen, examine, evaluate, treat/prevent! Kudos 4 focus on proactive diagnosis The...

Twitter summary: USPSTF releases draft rec. on #T2D screening – defines “at risk” population as 45+, overweight/obese, or 1 st –degree relative w/ #diabetes The United...

On April 29, the FDA issued a strongly-worded safety communication that advised patients and health care providers to stop using the GenStrip from Shasta Technologies, a...

The Centers for Disease Control (CDC) has released its new data on the state of diabetes in the United States, providing an update on its 2011 National Diabetes Fact...

Twitter Summary: FDA regulations will require chain restaurants, vending machines, + others to provide calorie counts of main menu items The FDA recently announced its...

Twitter Summary: @AmDiabetesAssn updates standards for medical care of #diabetes – suggests all #PWD use statin therapy, and a new BMI cutoff for Asian Americans The...

The symptoms, who is at risk, and what every patient on SGLT-2 inhibitors can do right now.

Take action to share your opinion on food labeling with the FDA!

Approved for those who can’t tolerate more statins – is this you?

Combining metformin and Jardiance into a single pill.

Agency seeks to integrate patient views in regulating devices.

Will this drug be cheaper than Lantus and other insulins?

Bringing added convenience to blood glucose monitoring in smartphone-connected device.

Increased focus on sleep, mental health, and behavior – what other changes were made?

Comment by March 26 to ensure that diabetes devices easily communicate with one another, other devices, and software.

Paving the way to healthier food options and preventing heart disease.

Launch before the second half of 2016. What savings program will be offered?

Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.

Plus, a new agreement to integrate the Gen 5 and Gen 6 Dexcom CGMs.

Public workshop scheduled at FDA for August 29, 2016. Get involved!